Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Participants With Hyperlipoproteinemia(a) and Cardiovascular Disease

Clinical trial NCT03070782 · COMPLETED

Trial details

NCT number: NCT03070782
Sponsor: Akcea Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Elevated Lipoprotein(a)Cardiovascular Disease

Start date: 2017-03-07
Primary completion: 2018-07-26
Enrollment: 286

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.